Stock Quote
AEterna Zentaris, Inc. (AEZS.W) (NASD ADF)
$1.01
30 Oct 2009
+1.00%
$1.00
$1.01
100
$1.01
$1.01
$3.25
$0.26
1.49
589,868
AEZS.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Ernst, Juergen | Executive Chairman of the Board | 514,636 |
| Engel, Jurgen | President, Chief Executive Officer, Director | 1,198,440 |
| Turpin, Dennis | Chief Financial Officer, Senior Vice President | 443,132 |
Profile
AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology. The Company’s product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products. The products of the Company include Cetrorelix, AEZS-108,... Full Description
Company Address
AEterna Zentaris, Inc.
1405 Parc-Technologique Blvd.
Quebec QC G1P 4P5
P: +1418.6528525
F: +1418.6520881
1405 Parc-Technologique Blvd.
Quebec QC G1P 4P5
P: +1418.6528525
F: +1418.6520881
Analyst Research
| AEZS.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 1.77 | 29.90 |
| ROI(TTM) | -66.52 | 2.35 |
| ROE(TTM) | -175.98 | 3.59 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -0.23 |
| EPS Est. (Current Year) | -0.88 |
| Total Revenue | $8.97M |
| Net Income | $-14.01M |
| EPS | $-0.26 |
